Published in South Med J on November 01, 1980
Clinical and biochemical significance of toxin production by Aeromonas hydrophila. J Clin Microbiol (1987) 1.18
Aeromonas hydrophila typing scheme based on patterns of agglutination with erythrocytes and yeast cells. J Clin Microbiol (1983) 1.06
Detection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. I. Methodology and immunologic properties of pneumococcal antigens. J Lab Clin Med (1973) 3.30
Determination of aetiology of bacterial meningitis by counter-immunoelectrophoresis. Lancet (1972) 3.18
Detection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. II. Etiologic diagnosis of pneumococcal pneumonia. J Lab Clin Med (1973) 2.55
Pneumococcal pneumonia: capsular polysaccharide antigenemia and antibody responses. Ann Intern Med (1976) 2.41
Detection by immunoelectrophoresis of antigen in sera of patients with pneumococcal bacteraemia. Lancet (1971) 2.24
Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol (1998) 1.75
Bacillus cereus pneumonia and bacteremia. A case report. Am Rev Respir Dis (1971) 1.70
Role of L3T4+ T cells in host defense against Histoplasma capsulatum. Infect Immun (1988) 1.68
Coagglutination and counterimmunoelectrophoresis for detection of pneumococcal antigens in the sputum of pneumonia patients. J Clin Microbiol (1980) 1.67
Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun (1997) 1.63
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest (1994) 1.56
Latex agglutination in the diagnosis of pneumococcal infection. J Clin Microbiol (1976) 1.55
Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol (1999) 1.54
Detection of influenza A and B in respiratory secretions with the polymerase chain reaction. PCR Methods Appl (1992) 1.47
Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun (1995) 1.44
Physical and immunologic properties of pneumococcal capsular polysaccharide produced during human infection. J Immunol (1974) 1.39
Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis (1997) 1.39
Urine as an antigen reservoir for diagnosis of infectious diseases. Am J Med (1983) 1.39
Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J Infect Dis (1993) 1.38
Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect Immun (1998) 1.32
Lymphocyte transformation in rickettsioses. J Immunol (1971) 1.32
Detection and partial characterization of antibacterial factor(s) in alveolar lining material of rats. J Clin Invest (1983) 1.27
Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.21
Detection of penumococcal antigens in the sputum in pneumococcal pneumonia. Am Rev Respir Dis (1977) 1.21
Comparison of histological and immunological techniques for detection of Pneumocystis carinii in rat bronchial lavage fluid. J Clin Microbiol (1980) 1.19
Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.19
Interaction of pneumococcal antigens with complement in rats. Infect Immun (1979) 1.17
Antigenemia in fulminant pneumococcemia. Ann Intern Med (1976) 1.17
Complement levels in pneumococcal pneumonia. Infect Immun (1977) 1.17
Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones. Infect Immun (1986) 1.16
Antibiotic susceptibility of Bacillus species. J Infect Dis (1971) 1.13
Characterization of the extracellular bactericidal factors of rat alveolar lining material. J Clin Invest (1984) 1.10
Regulation of infection with Histoplasma capsulatum by TNFR1 and -2. J Immunol (2000) 1.10
Medical mycology in crisis. J Lab Clin Med (1983) 1.06
An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell-mediated immune responses and protection in mice. Infect Immun (1992) 1.06
Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis. J Clin Invest (1998) 1.06
Comparative role of complement in pneumococcal and staphylococcal pneumonia. Infect Immun (1982) 1.04
Histoplasma acquisition of calcium and expression of CBP1 during intracellular parasitism. Mol Microbiol (1998) 1.03
Modulation of cellular immune responses in mice with disseminated histoplasmosis by recombinant interleukin-2. Infect Immun (1986) 1.03
Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect Immun (1999) 1.02
Functional assay of the alternative complement pathway of rat serum. J Immunol Methods (1979) 1.01
Characterization of antigenic determinants in histoplasmin that stimulate Histoplasma capsulatum-reactive T cells in vitro. Infect Immun (1988) 0.98
The URA5 gene is necessary for histoplasma capsulatum growth during infection of mouse and human cells. Infect Immun (1999) 0.98
Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. Am J Respir Cell Mol Biol (1994) 0.97
Immunoelectrophoresis for detection of polysaccharides in immune complexes. J Clin Microbiol (1978) 0.97
Stress proteins in fungal diseases. Med Mycol (1998) 0.97
Cellular immune responses to recombinant heat shock protein 70 from Histoplasma capsulatum. Infect Immun (1996) 0.97
Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection. Clin Exp Immunol (1988) 0.95
Development of vaccines and their use in the prevention of fungal infections. Med Mycol (1998) 0.94
V beta 6+ and V beta 4+ T cells exert cooperative activity in clearance of secondary infection with Histoplasma capsulatum. J Immunol (2001) 0.93
Bioavailability and pain study of cefamandole nafate. J Clin Pharmacol (1981) 0.91
Histoplasma capsulatum strain variation in both H antigen production and beta-glucosidase activity and overexpression of HAG1 from a telomeric linear plasmid. Infect Immun (1999) 0.90
Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis. J Immunol (1984) 0.90
Effect of rat alveolar lining material on macrophage receptors. J Immunol (1983) 0.90
Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae. Rev Infect Dis (1981) 0.90
Applying in vivo expression technology (IVET) to the fungal pathogen Histoplasma capsulatum. Microb Pathog (2000) 0.90
Spinal epidural abscess: an unusual complication of a duodenal ulcer. J Clin Gastroenterol (1990) 0.90
Early clearance of pneumococci from the lungs of decomplemented rats. Infect Immun (1982) 0.89
Molecular cloning, characterization and expression of the heat shock protein 60 gene from the human pathogenic fungus Paracoccidioides brasiliensis. Med Mycol (2001) 0.88
Experimental type 25 pneumococcal pneumonia in rats: an electron-microscopic study. Am J Pathol (1980) 0.87
Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone. Infect Immun (1993) 0.86
Pulmonary opsonins in Klebsiella pneumoniae pneumonia in rats. Infect Immun (1981) 0.85
Subdural empyema. Am J Med (1972) 0.85
CIE detection of bacterial antigens in meningitis. J Pediatr (1977) 0.84
Unexplained fever in burn patients due to cytomegalovirus infection. JAMA (1982) 0.84
Evidence of breakdown of pneumococcal polysaccharides in vivo. Proc Soc Exp Biol Med (1979) 0.83
Etiologic diagnosis of intrapleural empyema by counterimmunoelectrophoresis. Am Rev Respir Dis (1976) 0.83
Recognition of Histoplasma capsulatum yeast-cell antigens by human lymphocytes and human T-cell clones. J Leukoc Biol (1992) 0.83
Antigenicity of type-specific pneumococcal polysaccharides in rats. Infect Immun (1976) 0.83
Complement receptors of rat macrophages. J Reticuloendothel Soc (1982) 0.82
Immunomodulation in the mycoses. J Med Vet Mycol (1992) 0.82
Pharmacological modulation of suppressor cell activity in mice with disseminated histoplasmosis. Infect Immun (1983) 0.81
Generation of disparate immunoregulatory factors in two inbred strains of mice with disseminated histoplasmosis. J Immunol (1982) 0.81
Interleukin-12 neutralization alters lung inflammation and leukocyte expression of CD80, CD86, and major histocompatibility complex class II in mice infected with Histoplasma capsulatum. Infect Immun (2000) 0.80
Infection with Histoplasma capsulatum: Host-fungus interface. Rev Iberoam Micol (1998) 0.80
Requirements for histoplasmin presentation by accessory cells to a Histoplasma capsulatum-reactive T-cell line. J Leukoc Biol (1989) 0.80
Type 1 and type 2 cytokines: from basic science to fungal infections. Med Mycol (1998) 0.80
Evolution of inflammatory response and cellular immune responses in a murine model of disseminated blastomycosis. Infect Immun (1985) 0.79
Organ-specific disposition of group B streptococci in piglets: evidence for a direct interaction with target cells in the pulmonary circulation. Pediatr Res (1990) 0.79
Impairment of granulomatous inflammatory response to Histoplasma capsulatum by inhibitors of angiotensin-converting enzyme. Infect Immun (1985) 0.78
Oxygen radical-dependent bacterial killing and pulmonary hypertension in piglets infected with group B streptococci. Am Rev Respir Dis (1990) 0.78
Complement-fixing antibody response in pneumococcal pneumonia. Infect Immun (1977) 0.77
Diagnosis of equine influenza by the polymerase chain reaction. J Vet Diagn Invest (1994) 0.77
Evaluation of a hemolytic assay of the alternative complement pathway in human serum. Am J Clin Pathol (1980) 0.77
Effect of rat surfactant lipids on complement and Fc receptors of macrophages. Infect Immun (1986) 0.77
Atypical mycobacterial lymphadenitis in an adult. Chest (1980) 0.77
Etiological diagnosis of influenza A virus by enzymatic radioimmunoassay. J Clin Microbiol (1984) 0.75
Influenza: will new diagnostic tests and antiviral drugs make a difference? Chest (2001) 0.75
Specificity of counter-immunoelectrophoresis in bacterial meningitis. Lancet (1972) 0.75
Sepsis after splenectomy: current status of pneumococcal vaccine. J Ky Med Assoc (1980) 0.75
Therapy of viral, mycoplasmal and rickettsial infections. Wis Med J (1971) 0.75
Simultaneous infection with Blastomyces dermatitidis and Cryptococcus neoformans. Med Mycol (1998) 0.75
Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate. Ann Pharmacother (1997) 0.75
Sputum counterimmunoelectrophoresis in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis (1980) 0.75
Resolution of influenzal pneumonia. IMJ Ill Med J (1980) 0.75
Different reactivity of rat alveolar and peritoneal macrophages with EAMC and anti-CR3 monoclonal antibodies. Immunol Lett (1987) 0.75
Human alveolar lining material and antibacterial defenses. Am Rev Respir Dis (1986) 0.75
Properdin levels in pneumonia. N Engl J Med (1973) 0.75
Combined action of 6-mercaptopurine and antibiotics on gram-negative bacteria in vitro. Proc Soc Exp Biol Med (1972) 0.75